NUOVA OMPI SRL

Italy, Padova, Piombino Dese

Report a bug?

Claim ownership and edit

Description

by AI

The core business of Nuova OMPL is the Design, Manufacturing, Distribution and Customer Service of Pharmaceutical primary packaging solutions made of glass. Nuova OMPL counts with over 110 years of experience in the pharmaceutical industry and around 40 years for our company. As of today, Approximately 80% of the world pharmaceutical production uses glass containers. We strive to meet the requests and needs of customers in over the 100 Countries we are supplying

Industries

Miscellaneous Nondurable Goods Merchant Wholesalers; Glass and Glass Product Manufacturing; Nonmetallic Mineral Product Manufacturing; Manufacturing

SIC

Nondurable Goods, Nec; Flat Glass; Stone, Clay, Glass, and Concrete Products; Manufacturing

Address:

VIA MOLINELLA 17 PIOMBINO DESE

PADOVA

35017 Italy

Website:

www.stevanatogroup.com

Revenue

Company is likely to buy

Pharmaceutical glass containers

Company is likely to sell

Glass vials
Glass closures for pharmaceutical use
Glass ampoules
Glass bottles for pharmaceutical use
Glass jars for pharmaceutical use
Glass stoppers for pharmaceutical use
Glass caps for pharmaceutical use
Glass droppers for pharmaceutical use
Glass syringes for pharmaceutical use
Glass needles for pharmaceutical use

Disclaimer:

IndexBox is not affiliated with, associated with, or endorsed by this company in any way. The information provided on this page, including company details, is solely for informational purposes. IndexBox makes no representations or warranties about the accuracy or completeness of the information provided.

All data and information is provided “as is” for informational purposes only, and is not intended for trading purposes or financial, investment, tax, legal, accounting or other advice. Please consult your broker or financial representative to verify pricing before executing any trade. IndexBox is not an investment adviser, financial adviser or a securities broker. None of the data and information constitutes investment advice nor an offering, recommendation or solicitation by IndexBox to buy, sell or hold any security or financial product, and IndexBox makes no representation (and has no opinion) regarding the advisability or suitability of any investment.